tbuckley/cabot-search huggingface dataset:
THU0256 Rheumatic diseases are the most common cause of long term disability (ltd) compared to other major disease groups (mdg) in urban, suburban and rural greek population
Authors: A Andrianakos, S Aslanides, F Christogiannis, P Trontzas, G Karanikolas, D Karamitsos, P Krachtis, C Voudouris, G Kaziolas, K Pantelidou, E Tavaniotou, A Georgountzos
Journal: Annals of the Rheumatic Diseases (2001)

<h3>Background</h3> <h3>Objectives</h3> To assess the prevalence of LTD caused by RD or any other MDG was one of the aims of a population-based epidemiological study of RD in Greece (ESORDIG study). <h3>Methods</h3> All adult (&gt;18 years) residents of two urban (U), one suburban (SU) and four rural (R) communities of Greece were included in this 3 year (1996–1999) study (8,547 subjects), along with 2,100 randomly selected subjects of 1 SU (1:3) and 1 R (1:2) communities. Sixteen rheumatologists performed the study and 8,740 adults were included (out of a total of 10,647, response rate 82.1%). The study included a detailed interview based on a standardised questionnaire. LTD was defined as ?the limitation of occupational or any other activities because of a long-term physical or mental disorder or health problem, compared to other people of the same age in good health?. Established classification criteria (ECC) were used for the diagnosis of RD, while, for the purpose of the study, such criteria were set for RD without ECC. <h3>Results</h3> From 2,393 subjects (out of 8,740, 27.4%) suffering from RD, 394 (16.5%) also had LTD. Thus, the prevalence of LTD caused by RD was 4.5% in the general population (GP), being higher in women (6.2%) than in men (2.8%, p &lt; 0.0005). LTD prevalence increased with age, being 11.6% in subjects &gt;68 years, while no significant differences were observed between the three (U, SU, R) communities. The total prevalence of LTD from any cause was 9.8% in the GP and RD were the most common cause, being responsible of 46.2% of all LTD, followed by cardiovascular diseases (CVD, 22.7%). Analysis for sex, age and community revealed that RD were always the leading cause of LTD, but in men aged &gt;58 years, CVD were first (41.3%), with RD second (25.4%). <h3>Conclusion</h3> The results of this study show that RD, compared with other MDG, are the leading cause of LTD in the general population. Since LTD is the major contributing factor for the total indirect cost of all MDG, these findings concerning RD appear to be of considerable value in planning rheumatology research and health care services.
Real-World Data of Azacytidine Efficacy As Front-Line Treatment for AML Non-Eligible for Intensive Treatment and High-Risk MDS: A Peruvian Multicenter Study
Authors: Angela Arbizu-Chipana, Daniel J Enriquez, Mariano Lopez-Pereyra, Claudio Flores, Tatiana Saldarriaga, Melissa Morales-Coloma, Lourdes Lopez, Jule F Vasquez, Shirley Quintana, Antonio Carrasco, Cesar Samanez-Figari
Journal: Blood (2020)
Platelet Storage Temperature Determines Recovery of GPVI-Function <i>In Vivo</i>
Authors: Jeffrey Miles, Chomkan Usaneerungrueng, Ava M. Obenaus, Molly Y Mollica, Jake R Flynn, Shawn Lawrence Bailey, Barbara Osborne, Jill Corson, Katie Houck, Jing-fei Dong, Nathan J. Sniadecki, Moritz Stolla
Journal: Blood (2020)
The Role of Alpha 2 Macroglobulin in Chronic Activation of the Complement System in Patients with Chronic Lymphocytic Leukemia
Authors: Naseba Naseraldeen, Regina Michelis, Masad Barhoum, Judith Chezar, Tamar Tadmor, Ariel Aviv, Lev Shvidel, Adi Litmanovich, Mona Yuklea, Mona Shehadeh, Ety Shaoul, Andrei Braester
Journal: Blood (2020)
Activating JAK-mutations confer resistance to FLT3 kinase inhibitors in FLT3-ITD positive AML in vitro and in vivo
Authors: Christoph Rummelt, Sivahari P. Gorantla, Manja Meggendorfer, Anne Charlet, Cornelia Endres, Konstanze Döhner, Florian H. Heidel, Thomas Fischer, Torsten Haferlach, Justus Duyster, Nikolas von Bubnoff
Journal: Leukemia (2020)
Development of a New Bone‐Mimetic Surface Treatment Platform: Nanoneedle Hydroxyapatite (nnHA) Coating
Authors: Kian F. Eichholz, Stanislas Von Euw, Ross Burdis, Daniel J. Kelly, David A. Hoey
Journal: Advanced Healthcare Materials (2020)

Abstract The hierarchical structure of bone plays pivotal roles in driving cell behavior and tissue regeneration and must be considered when designing materials for orthopedic applications. Herein, it is aimed to recapitulate the native bone environment by using melt electrowriting to fabricate fibrous microarchitectures which are modified with plate‐shaped (pHA) or novel nanoneedle‐shaped (nnHA) crystals. Nuclear magnetic resonance spectroscopy, scanning electron microscopy, transmission electron microscopy, and X‐ray diffraction demonstrate that these coatings replicate the nanostructure and composition of native bone. Human mesenchymal stem/stromal cell (MSC) mineralization is significantly increased fivefold with pHA scaffolds and 14‐fold with nnHA scaffolds. Given the protein stabilizing properties of mineral, these materials are further functionalized with bone morphogenetic protein 2 (BMP2). nnHA treatment facilitates controlled release of BMP2 which further enhance MSC mineral deposition. Finally, the versatility of this nnHA treatment method, which may be used to coat different architectures/materials including fused deposition modeling (FDM) scaffolds and Ti6Al4V titanium, is demonstrated. This study thus outlines a method for fabricating scaffolds with precise fibrous microarchitectures and bone‐mimetic nnHA extrafibrillar coatings which significantly enhance MSC osteogenesis and therapeutic protein delivery, and leverages these results to show how this surface treatment method may be applied to a wider field for multiple orthopedic applications.
Mesenchymal Stem Cells (MSCs) Intensify the Impact of KIR Ligand-Mismatching on Acute Graft-Versus-Host Disease Post HSCT in Patients with Acute Myeloid Leukemia but Not with Acute Lymphocytic Leukemia
Authors: Yu Zhang, Shaozhen Chen, Jinhua Ren, Xiaofeng Luo, Zhizhe Chen, Jianda Hu, Ting Yang
Journal: Blood (2020)
Quizartinib with Decitabine +/- Venetoclax Is Highly Active in Patients (Pts) with <i>FLT3</i>-ITD Mutated (mut) Acute Myeloid Leukemia (AML): Clinical Report and Signaling Cytof Profiling from a Phase IB/II Trial
Authors: Musa Yilmaz, Hagop M. Kantarjian, Muharrem Muftuoglu, Tapan M. Kadia, Marina Konopleva, Gautam Borthakur, Courtney D. DiNardo, Naveen Pemmaraju, Nicholas J. Short, Yesid Alvarado, Guillermo Montalban Bravo, Carissa Jurisprudencia, Allison M. Pike, Maro Ohanian, Elias Jabbour, Guillermo Garcia-Manero, Vivian Ruvolo, Farhad Ravandi, Michael Andreeff, Naval Daver
Journal: Blood (2020)
Venetoclax Plus Hypomethylating Agents for Relapsed/Refractory Acute Myeloid Leukemia (AML) Is Safe and Manageable in the Outpatient Setting
Authors: Jacopo Nanni, Cristina Papayannidis, Gianluca Cristiano, Giovanni Marconi, Chiara Sartor, Sarah Parisi, Emanuela Ottaviani, Lorenza Baldini, Nicoletta Testoni, Carmen Baldazzi, Paolo Ricci, Chiara Di Giovanni Bezzi, Rania Abd-alatif, Stefania Paolini, Michele Cavo, Antonio Curti
Journal: Blood (2020)
Association of Gene Polymorphisms in Cyclophosphamide Metabolism Pathway with Complications after Haploidentical Hematopoietic Stem Cell Transplantation
Authors: Paula Muñiz Sevilla, Cristina Andres, Diego Carbonell, María Chicano Lavilla, Rebeca Bailen, Gillen Oarbeascoa, Julia Suárez González, Javier Anguita, Mi Kwon, Jose L. Diez-Martin, Carolina Martínez-Laperche, Ismael Buño
Journal: Blood (2020)
Abstract 486: Chronic Periodontitis Induces Adverse Post-myocardial Wound Healing Through Activation of CD8+ T-cells
Authors: Yusra Zaidi, Miguel Troncoso, Daria Ilatovskaya, Kristine Y Deleon-pennell
Journal: Circulation Research (2020)

Increased risk of adverse cardiac remodeling post-myocardial infarction (MI) has been observed in patients with periodontal disease. Previously, we demonstrated that chronic inflammation induced by periodontal pathogen Porphyromonas gingivalis lipopolysaccharide (LPS) resets cardiac homeostasis, causing acceleration and exacerbation of the macrophage response post-MI. We hypothesize that chronic LPS activates a memory T-cell response resulting in adverse cardiac remodeling post-MI. Analysis of the mouse heart attack research tool (mHART) 1.0 identified 135 mice (5.4 ± 0.1 months of age) associated with the LPS study that had both echo and plasma data collected. Of these 26 mice also had tissue blocks in the mHART tissue bank. Mice were grouped as follows: 1) Saline day 0 unoperated mice (D0), 2) 28 day LPS day 0 unoperated mice (LPS), 3) Saline day 1 MI (MI), and 4) 28 day LPS day 1 MI (LPS+MI). Immunofluorescence of the left ventricle (LV) demonstrated that chronic LPS increased the number of memory CD8+ T-cells (CD3+CD8+CD27+) in the LV and remained elevated in the LPS+MI group compared to D0 and MI controls. Similar to chronic LPS, ligature-induced periodontitis (21 days) also showed upregulation of CD8+ T-cells in the LV along with changes in plasma proteins associated with interleukin, cytokine, chemokine receptor binding, peptide ligand-binding, inflammasome pathway, class A/1 rhodopsin-like receptors, G-protein coupled receptor ligand binding, and RUNX1 and FOXP3 control of Treg development and signaling. To dissect T-cell mediated signaling pathways, we constantly infused an MHC-I blocking antibody (MHCi; 0.2 μg/day; n=3) by osmotic mini-pumps implanted subcutaneously 7 days before (21 days after LPS infusion) and after MI surgery. Interestingly, MHCi attenuated the effector CD8+ T-cell response (CD3+CD8+CD44+) without affecting the memory response. MHCi also attenuated macrophage numbers within the infarct, thereby improving cardiac function at post-MI day 1. Our data showed the recruitment of effector but not memory CD8+ T-cells is regulating macrophage-mediated adverse post-MI remodeling in the setting of chronic periodontitis.
Helen Salisbury: Postponing death
Authors: Helen Salisbury
Journal: BMJ (2020)

A newspaper columnist recently suggested on social media that responding to the pandemic with a lockdown does not prevent deaths but merely postpones them.Unsurprisingly, there was pushback.Until someone discovers the secret of eternal life on Earth, death can't be prevented.Postponing it is, however, the main purpose of medicine, alongside reducing suffering.Perhaps what the columnist meant was that the most vulnerable people will catch the virus anyway and some will die, so efforts to slow the spread are merely prolonging harm.If we can't prevent excess deaths from happening, we may as well get them over and done with quickly, to allow our economy to reopen and flourish once more.
Maintenance Treatment with Guadecitabine (SGI-110) in High Risk MDS and AML Patients after Allogeneic Stem Cell Transplantation
Authors: Betul Oran, Gheath Alatrash, Amin M. Alousi, Rohtesh S. Mehta, Chitra Hosing, Uday R. Popat, Jin S. Im, Jessica M McCarty, Jennifer D Ramos, Harold N. Keer, Peter F Thall, Richard E. Champlin
Journal: Blood (2020)
Nonhematopoietic Nrf2 Deficiency Worsens Chronic Intravascular Hemolysis but Not Cardiomyopathy in Transgenic Sickle Cell Mice
Authors: Maureen Mburu, Samit Ghosh, Xucai Chen, Solomon Fiifi Ofori-Acquah, Flordeliza S Villanueva
Journal: Blood (2020)
Alteration of the Renin–Angiotensin–Aldosterone System in Shock: Role of the Dipeptidyl Peptidase 3
Authors: Adrien Picod, Benjamin Deniau, Prabakar Vaittinada Ayar, Magali Genest, Nathan Julian, Feriel Azibani, Alexandre Mebazaa
Journal: American Journal of Respiratory and Critical Care Medicine (2020)

First Page
Single-Cell Profiling of Signal Transduction Pathways in Pediatric T-Cell Acute Lymphoblastic Leukemia By Mass Cytometry:Dissecting JAK/STAT and PI3K/Akt/mTOR Active Signalling
Authors: Daniela Kužílková, Tomas Kalina, Cristina Bugarin, Katerina Rejlová, Daniel Thurner, Pavel Semerák, Jan Stuchly, Andrea Biondi, Giuseppe Gaipa
Journal: Blood (2020)
Causes of Death in Non-Follicular Indolent B-Cell Lymphoma in the Rituximab Era
Authors: Aung M Tun, Raphael Mwangi, Brian K. Link, Andrew L. Feldman, Matthew J. Maurer, Thomas E. Witzig, Carrie A. Thompson, Anne J. Novak, Jose C Villasboas, Umar Farooq, Sergei Syrbu, James R. Cerhan, Thomas M. Habermann
Journal: Blood (2020)
Tapering Thrombopoietin Receptor Agonists in Primary Immune Thrombocytopenia: Recommendations Based on the RAND/UCLA Modified Delphi Panel Method
Authors: Adam Cuker, Jenny M. Despotovic, Rachael F. Grace, Caroline Kruse, Michele P. Lambert, Howard Liebman, Roger M. Lyons, Keith R McCrae, Vinod A. Pullarkat, Jeffrey Wasser, David Beenhouwer, Sarah N Gibbs, Irina Yermilov, Michael S Broder
Journal: Blood (2020)
AB0191 Prevalence of osteoporosis among female systemic lupus erythematosus patients
Authors: O Di Munno, M Mazzantini, M Mosca, S Frigelli, A Delle Sedie, R Neri, S Bombardieri
Journal: Annals of the Rheumatic Diseases (2001)

<h3>Background</h3> It has been reported that bone mineral density (BMD) is significantly reduced in premenopausal SLE patients as compared to controls and that 12–25% of such patients are considered to have osteoporosis (OP). Furthermore, SLE patients have a 5-fold probability of sustaining a fracture as compared to the normal population. Long term glucocorticoids (GC) and immunosoppressive drugs are likely to play a major role in the pathogenesis of bone loss. <h3>Objectives</h3> Aim of the present study was to assess BMD and OP prevalence among ambulatory female SLE patients with respect to a normal population. <h3>Methods</h3> Thirty-two pre- (mean age 36 ± 9 years) and 14 postmenopausal (mean age 57 ± 8) patients have been enrolled so far. Exclusion criteria were: any other disease known to affect bone mass, renal insufficiency (serum cretinine &gt; 2 mg/dl for &gt; 6 months), any treatment for &gt; 1 month for the prevention and treatment of bone loss, excluded calcium and vitamin D supplementation. Lumbar and femoral BMD were measured by dual x-ray absorptiometry (DXA). All patients were receiving GC at the time of the study. Variables included were: body mass index, disease duration, activity (ECLAM) and damage (SLICC), duration of GC treatment, cumulative dose of GC (either by pulse therapy and daily oral dose), and use of the immunosoppressive agent cyclophosphamide. <h3>Results</h3> In premenopausal patients mean lumbar BMD was 0.96 ± 0.13 g/cm<sup>2</sup> (mean T-score -0.8 ± 1.2), and femoral BMD was 0.87 ± 0.19 g/cm<sup>2</sup> (T-score – 0.8 ± 1.1); in postmenopausal patients lumbar BMD was 0.85 ± 0.13 g/cm<sup>2</sup> (T-score -1.8 ± 1.2) and femoral BMD 0.84 ± 0.11 (T-score -1.2 ± 0.9). OP, defined as a T-score below 2.5 SD compared to a reference population of young healthy women in at least one region of measurement, was detected in 4 (12.5%) premenopausal and in 3 (21.4%) postmenopausal patients. Comparison to the normal population and the correlations between BMD and the variables included will be evaluated only after the completion of the recruitment. <h3>Conclusion</h3> These preliminary results show in our SLE patients a prevalence of OP which is similar to that reported in other series. The role of the variables included in the analysis will help understand the pathogenesis of bone loss.
Audio Interview: What the U.S. Response to Covid-19 Looks Like Today
Authors: Eric J. Rubin, Lindsey R. Baden, Stephen Morrissey
Journal: New England Journal of Medicine (2020)

What the U.S. Response to Covid-19 Looks Like Today In this audio interview conducted on November 4, 2020, the editors assess the current state of the U.S. response to Covid-19: vaccines, therapeut...
Transcription Factor RUNX1 Regulates Factor FXIIIA Subunit (<i>F13A1</i>) Expression in Megakaryocytic Cells and Platelet <i>F13A1 Expression</i> is Downregulated in <i>RUNX1</i> Haplodeficiency
Authors: Natthapol Songdej, Fabiola Del carpio-cano, Guangfen Mao, Jeremy Wurtzel, Lawrence Goldfinger, Michele P. Lambert, Angara Koneti Rao
Journal: Blood (2020)
TANK-Binding Kinase 1 Regulates the Localization of Acyl-CoA Synthetase ACSL1 to Control Hepatic Fatty Acid Oxidation
Authors: Jin Young Huh, Shannon M. Reilly, Mohammad Abu-Odeh, Anne N. Murphy, Sushil K. Mahata, Jinyu Zhang, Yoori Cho, Jong Bae Seo, Chao-Wei Hung, Courtney R. Green, Christian M. Metallo, Alan R. Saltiel
Journal: Cell Metabolism (2020)
Robust Pre-Clinical Results and Large-Scale Manufacturing Process for Edit-301: An Autologous Cell Therapy for the Potential Treatment of SCD
Authors: Edouard De Dreuzy, Jack Heath, Patricia Sousa, Tusneem Janoudi, Harry An, Scott Hansen, David K. Wood, Charles F Albright, Sandra Teixeira, Tamara Monesmith, Kate Zhang, Kai-Hsin Chang
Journal: Blood (2020)
Adolescent and Young Adult Hodgkin Lymphoma: Is More Better?
Authors: Reghu K Sukumaran Nair, Vivek S Radhakrishnan, Avijeet K Mishra, Vinay A Guntiboina, Saurabh J Bhave, Jeevan Kumar Garg, Indu Arun, Lateef Zameer, Debdeep Dey, Neeraj Arora, Deepak K Mishra, Arpita Bhattacharyya, Niharendu Ghara, Rimpa B Achari, Shekhar Krishnan, Mammen Chandy, Reena Nair
Journal: Blood (2020)
Comparative Analysis for Differential Drug Response between Early T-Cell Precursor Acute Lymphoblastic Leukemia (ETP-ALL) and T-Cell Acute Lymphoblastic Leukemia (T-ALL) Patients Using the Cellworks Omics Biology Model (CBM): Mycare-021-03
Authors: Scott Howard, Ansu Kumar, Anusha Pampana, Yashaswini S Ullal, Anuj Tyagi, Deepak Anil Lala, Pallavi Kumari, Vishwas Joseph, Karthik Sundara Raju, Veena Balakrishnan, Nirjhar Mundkur, Michele Dundas Macpherson, Prashant Ramachandran Nair, Shweta Kapoor
Journal: Blood (2020)
Practice Patterns and Real-Life Outcomes for Patients with Acute Promyelocytic Leukemia
Authors: Jan Philipp Bewersdorf, Stephanie Prozora, Rong Wang, Nikolai A. Podoltsev, Rory M. Shallis, Scott F. Huntington, Natalia Neparidze, Xiaomei Ma, Steven D. Gore, Amer M. Zeidan, Amy J. Davidoff
Journal: Blood (2020)
Ceramide in apoptosis and oxidative stress in allergic inflammation and asthma
Authors: Briana N. James, Clement Oyeniran, Jamie L. Sturgill, Jason Newton, Rebecca K. Martin, Erhard Bieberich, Cynthia Weigel, Melissa A. Maczis, Elisa N.D. Palladino, Joseph C. Lownik, John B. Trudeau, Joan M. Cook-Mills, Sally Wenzel, Sheldon Milstien, Sarah Spiegel
Journal: Journal of Allergy and Clinical Immunology (2020)
Studies in the Epidemiology of Tinea Pedis--VII
Authors: M. P. English
Journal: BMJ (1961)

TINEA PEDIS BRrrisHThe relationship to fungal infection of lesions of nonfungal origin is discussed, and it is concluded that, though such lesions may sometimes predispose to fungal infection, other, unknown, factors are also involved.We are grateful to Dr. C. Bernard for his assistance with this survey.We acknowledge the kindness of the headmaster in allowing us to visit his school, and of the matron for her ready co-operation during our visits.We are indebted to Miss E.
Universal Sensitive, Accurate and Precise Microchimerism Surveillance Solution for Allogeneic Hematopoietic Cell Transplant
Authors: Camila Egidio, Vasantharajan Janakiraman, Qing Mao, Natali Gulbahce, Lily Wong, Corina Marchis, Srinka Ghosh, Marica Grskovic
Journal: Blood (2020)
DREAMM-8: A Phase III Study of the Efficacy and Safety of Belantamab Mafodotin with Pomalidomide and Dexamethasone (B-Pd) Vs Pomalidomide Plus Bortezomib and Dexamethasone (PVd) in Patients with Relapsed/Refractory Multiple Myeloma (RRMM)
Authors: Suzanne Trudel, Randy Davis, Nicole M. Lewis, Kalpana K. Bakshi, Bikramjit Chopra, Rocio Montes de Oca, Geraldine Ferron-Brady, Laurie Eliason, Brandon E. Kremer, Ira Gupta, Frank S. Wu
Journal: Blood (2020)
Abstract 476: Mitochondrial DNA Preservation Preserves Cardiac Function Following Sudden Cardiac Arrest
Authors: Cody A Rutledge, Kevin Redding, Cameron Dezfulian, Brett A Kaufman
Journal: Circulation Research (2020)

Background: Sudden cardiac arrest (SCA) affects over 350,000 Americans yearly with greater than 70% mortality. Survivors frequently develop cardiomyopathy after SCA. Cardiac reperfusion causes mitochondrial ROS production, which is known to damage mitochondrial DNA (mtDNA), but the physiologic consequences of mtDNA damage are unclear. We investigated the role of mtDNA damage by altering the expression of TFAM, a nuclear-encoded transcription factor that protects mtDNA from ROS, in a mouse model of SCA. Methods: WT and transgenic mice featuring cardiac-specific TFAM overexpression (TFAM-OE) and under-expression (TFAM Flox) underwent either 8 min of SCA or sham surgery followed by cardiopulmonary resuscitation. Survivors were assessed by echocardiography at 1-day, 1-week, and 4-weeks. Tissues were collected for assessment of mtDNA copy number and damage and assessment of mitochondrial morphology, protein expression, and function. Results: WT, TFAM-OE, and TFAM Flox mice had no significant changes to baseline body weight or ejection fraction (EF). There were no changes in time to return of spontaneous circulation or body temperature between groups. 1 day after SCA, WT mice have reduced EF (38.49±3.76%) compared to sham WT mice (59.73±1.42). EF is protected in TFAM-OE mice (51.11±2.95%) and exacerbated in TFAM-UE mice (29.36±5.40%). TFAM-OE have significantly higher survival at 4 weeks (80%, 8 of 10) when compared to WT mice (38%, 5 of 13), but there is no change in TFAM-Flox mice (43%, 3 of 7). TFAM OE mice have higher mtDNA copy number and lower mtDNA damage when compared to WT mice. Conclusions: TFAM OE protects cardiac function 1-day after SCA and improves 4-week survival. This is likely driven by TFAM-mediated protection of mtDNA. TFAM-Flox mice have lower EF at one day but no change to survival. This work suggests a role for mtDNA damage as a mechanism and potential therapeutic target of cardiomyopathy after SCA.
Abstract 11789: Implications of the 2017 American College of Cardiology/American Heart Association Hypertension Guideline in a Multi Ethnic Cohort: MESA
Authors: Charles German, John W McEvoy, Michael J Blaha, Alain Bertoni, Michael D Miedema, Gregory L Burke, Joseph Yeboah
Journal: Circulation (2018)

Introduction: The American College of Physicians (ACP) and the American Academy of Family Physicians (AAFP) did not endorse the 2017 American College of Cardiology/American Heart Association (ACC/A...
Inhibition of Immune Cell Subsets Is Differentially Affected By Dasatinib Dosage in Patients with Chronic Phase CML
Authors: Patrick Harrington, Richard Dillon, Deepti H. Radia, Donal P. McLornan, Philippe Rousselot, Katayoun Rezvani, Shahram Kordasti, Claire Harrison, Hugues de Lavallade
Journal: Blood (2020)
Covid-19 Disease Is Not Associated with Venous Thromboembolism in a Cohort of Patients in Jeddah, Saudi Arabia
Authors: Fatemah Kamel, Rania Magadmi, Sulafa Alqutub, Maha A. Badawi, Fatin Al-Sayes, Mazen Badawi, Tariq Madani, Soheir Adam
Journal: Blood (2020)
Retrospective Evaluation of Rituximab, Methotrexate, Procabazine, Vincristine and Etoposide Followed By Consolidation with Rituximab, Aracytine and Ifosfamide for Elderly Patients with Newly Diagnosed Primary CNS Lymphoma
Authors: Gabriel Antherieu, Edith Julia, Emmanuelle Nicolas-Virelizier, Marie-Charlotte Laude, Violaine Safar, Philippe Rey, Emmanuelle Ferrant, Alexandra Traverse-Glehen, Catherine Chassagne-Clément, David Meyronet, Anne Lazareth, Helene Lequeu, Camille Golfier, Gabriel Brisou, Dana Ghergus, Pierre Sesques, Lionel Karlin, Fadhela Bouafia, Gilles Salles, Emmanuel Bachy, François Ducray, Youenn Drouet, Herve Ghesquieres
Journal: Blood (2020)
A Multicenter Phase 1/2 Clinical Trial of Tagraxofusp, a CD123-Targeted Therapy, in Patients with Poor-Risk Primary and Secondary Myelofibrosis
Authors: Naveen Pemmaraju, Vikas Gupta, Haris Ali, Abdulraheem Yacoub, Eunice S. Wang, Sangmin Lee, Gary J. Schiller, Christopher Brooks, Nicole Rupprecht, Animesh Pardanani, Ayalew Tefferi, Moshe Talpaz, Minakshi S. Taparia, Tariq I. Mughal, Srdan Verstovsek, Joseph D. Khoury, Mrinal M. Patnaik
Journal: Blood (2020)